- Home
- ESLA vs OM Comparison
ESLA vs OM Comparison
Compare ESLA & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.08
HOLD
Current Price
$4.90
Company Overview
Basic Information| Metric | ESLA | OM |
|---|---|---|
| Founded | 2021 | 2003 |
| Country | United States | United States |
| Employees | N/A | 310 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.5M | 92.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ESLA | OM |
|---|---|---|
| Price | $1.08 | $4.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $8.00 | ★ $13.33 |
| AVG Volume (30 Days) | 24.7K | ★ 174.5K |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,476,000.00 |
| Revenue This Year | N/A | $9.29 |
| Revenue Next Year | N/A | $10.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $0.78 | $3.00 |
| 52 Week High | $3.15 | $21.98 |
Technical Indicators
Market Signals| Indicator | ESLA | OM |
|---|---|---|
| Relative Strength Index (RSI) | 33.15 | 64.74 |
| Support Level | $0.97 | $4.06 |
| Resistance Level | $1.35 | $5.94 |
| Average True Range (ATR) | 0.09 | 0.37 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 16.67 | 76.96 |
Price Performance
Historical Comparison ESLA
OM
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.